Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bisphosphonates for malignancy-related bone disease: current status, future developments.

Jean-Jacques Body1

  • 1Department of Internal Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Belgium. jj.body@bordet.be

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|February 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Randomized Phase 1 Study Comparing the PK, PD, Safety, and Immunogenicity of Proposed Biosimilar RGB-14-X and Denosumab in Healthy Adult Males.

Clinical and translational science·2026
Same author

Association between sarcopenia, its components, and osteoporosis in the FRISBEE cohort.

BMC musculoskeletal disorders·2025
Same author

Corrigendum to "The Totality of Evidence for SDZ-deno: A Biosimilar to Reference Denosumab" [Clin Ther. 2024;46:916-926].

Clinical therapeutics·2025
Same author

Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG.

Journal of bone oncology·2025
Same author

Osteosarcopenia, sarcopenia, and their associations with validated recent fragility fractures in older women: applying seven definitions in the FRISBEE 2 study.

European geriatric medicine·2025
Same author

Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same journal

Building a comparative evidence framework for breakthrough cancer pain.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Financial toxicity among breast cancer survivors receiving care during the pandemic.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Patients' expectations and barriers towards postoperative telehealth follow-up after oncologic breast surgery in France.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Reduced expression of N-methyl-D-aspartate receptor and calcium signaling genes in gray matter is associated with cancer-related cognitive impairment.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Adult cancer survivors' perceptions of immersive virtual reality exercise and its utility during chemotherapy infusion: a concurrent mixed method exploratory study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Efficacy of different non-pharmacological therapies on cancer-related fatigue in breast cancer patients: a network meta-analysis.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
See all related articles

Bisphosphonates effectively prevent skeletal-related events and reduce bone pain in patients with metastatic bone disease. Emerging research suggests broader applications, including adjuvant therapy and managing cancer treatment-induced bone loss.

Area of Science:

  • Oncology
  • Pharmacology
  • Bone Metabolism

Background:

  • Metastatic bone disease poses significant challenges, including skeletal-related events (SREs) and bone pain.
  • Bisphosphonates are a cornerstone therapy for managing bone complications in cancer patients.

Purpose of the Study:

  • To review the efficacy and safety of bisphosphonates in metastatic bone disease.
  • To discuss current recommendations and future indications for bisphosphonate therapy.

Main Methods:

  • Review of Phase III clinical trials and randomized trials evaluating bisphosphonates (clodronate, pamidronate, zoledronic acid, ibandronate).
  • Assessment of efficacy in preventing SREs, reducing bone pain, and improving quality of life.
  • Consideration of drug tolerability and emerging therapeutic applications.

Related Experiment Videos

Main Results:

  • Established efficacy of clodronate, pamidronate, and zoledronic acid in reducing SREs across various cancers (breast, multiple myeloma, prostate, lung).
  • Demonstrated efficacy of ibandronate (oral and intravenous) in preventing skeletal events and alleviating bone pain.
  • Bisphosphonates show a positive impact on metastatic bone pain and quality of life.

Conclusions:

  • Bisphosphonates are effective in managing metastatic bone disease by preventing SREs and reducing pain.
  • Future applications may include adjuvant therapy and treatment of cancer treatment-induced bone loss, expanding their role in oncology.